cardiovascular
-
Health
The Hidden Risks of Stopping GLP-1 Medications for Cardiovascular Health
The meteoric rise of glucagon-like peptide-1 (GLP-1) receptor agonists—a class of drugs that includes semaglutide (marketed as Ozempic and Wegovy)…
Read More » -
Health
The Hidden Toll of Chronic Stress: How Everyday Life Remodels the Heart and Escalates Cardiovascular Risk
For decades, the medical community has recognized the broad, systemic impact of chronic stress on human health. However, a landmark…
Read More » -
Education
Millions of Americans Fall Short of Cardiovascular Health Goals as New 2026 Cholesterol Guidelines Reveal Major Treatment Gaps
A landmark study led by investigators from Mass General Brigham has revealed a staggering disconnect between the current cardiovascular health…
Read More »
